Related Experiment Video

Updated: Sep 29, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

[Diprivan-EDTA--choice in favor of patients safety]

A M Ovechkin, Iu V Gagarina

    Anesteziologiia I Reanimatologiia
    |September 12, 2002
    PubMed

    Insights

    Bacterial contamination of propofol can cause complications. A new propofol formula, diprivan-EDTA, shows antibacterial properties and may reduce severe postoperative complications and mortality.

    Area of Science:

    • Anesthesiology and pharmacology
    • Microbiology and infectious diseases

    Context:

    • Propofol is widely used in anesthesia, with increasing annual utilization.
    • Bacterial contamination of propofol solutions during use poses a risk, potentially causing postoperative complications in 6.3% of cases.

    Purpose:

    • To introduce a modified propofol formula, diprivan-EDTA, with inherent antibacterial properties.
    • To evaluate the preliminary clinical safety and efficacy of diprivan-EDTA in reducing postoperative complications.

    Summary:

    • A novel diprivan-EDTA formulation has been developed, exhibiting bacteriostatic effects against 20 common microorganisms.
    • Preliminary clinical data suggest diprivan-EDTA positively influences the incidence of severe postoperative complications and patient mortality in intensive care.

    Impact:

    • Diprivan-EDTA may offer a safer alternative for anesthesia, mitigating risks associated with propofol contamination.
    • Potential reduction in severe postoperative complications and mortality rates in critical care settings.

    Related Concept Videos

    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

    Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

    Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
    Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
    Effects of EDTA on End-Point Detection Methods01:18

    Effects of EDTA on End-Point Detection Methods

    Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
    In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    Masking and Demasking Agents01:19

    Masking and Demasking Agents

    EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
    There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on the metal...
    EDTA: Chemistry and Properties01:22

    EDTA: Chemistry and Properties

    Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
    EDTA: Auxiliary Complexing Reagents01:26

    EDTA: Auxiliary Complexing Reagents

    EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...